IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5878.86M
Enterprise Value 3613.79M
Trailing P/E N/A
Forward P/E 1-8.77
PEG Ratio (5 yr expected) 10.46
Price/Sales (ttm)N/A
Price/Book (mrq)5.26
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-8.50

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.69%
Return on Equity (ttm)-47.54%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -72.23M
Net Income Avi to Common (ttm)-81.9M
Diluted EPS (ttm)-1.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)163.38M
Total Cash Per Share (mrq)2.25
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)20.09
Book Value Per Share (mrq)2.30

Cash Flow Statement

Operating Cash Flow (ttm)-69.9M
Levered Free Cash Flow (ttm)-35.65M

Trading Information

Stock Price History

Beta 1.71
52-Week Change 356.95%
S&P500 52-Week Change 324.25%
52 Week High 312.25
52 Week Low 34.45
50-Day Moving Average 38.77
200-Day Moving Average 37.37

Share Statistics

Avg Vol (3 month) 3549.33k
Avg Vol (10 day) 31.05M
Shares Outstanding 572.63M
Float 51.1M
% Held by Insiders 17.10%
% Held by Institutions 183.70%
Shares Short 32.37M
Short Ratio 34.93
Short % of Float 34.32%
Shares Short (prior month) 32.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/100
Last Split Date 3Sep 26, 2013